Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 46 min 24 sec ago

Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer

Mon, 08/08/2016 - 13:20
LOUISVILLE, Ky., Aug. 8, 2016 -- (Healthcare Sales & Marketing Network) -- Apellis Pharmaceuticals, Inc., a clinical stage complement immunotherapy company, announced today the expansion of its executive team with the addition of Dr. Robert Kim as its Chi...
Biopharmaceuticals, Personnel
Apellis Pharmaceuticals

Araim Pharmaceuticals Announces Appointment of Ferdinand C. Breedveld, M.D. as Chairman of the Board

Mon, 08/08/2016 - 13:13
TARRYTOWN, N.Y., Aug. 8, 2016 -- (Healthcare Sales & Marketing Network) -- Araim Pharmaceuticals, a clinical stage pharmaceutical company, announced today that Ferdinand Breedveld, M.D. has been selected as the new Chairman of the Board, effective immedia...
Biopharmaceuticals, Personnel
Araim Pharmaceuticals, Innate Repair Receptor

Virtual Colonoscopy Receives Highest Grade in the New U.S. Preventive Services Task Force Recommendation for Colorectal Cancer Screening

Fri, 08/05/2016 - 15:22
MONROE TOWNSHIP, N.J., Aug. 5, 2016 -- (Healthcare Sales & Marketing Network) -- Bracco Diagnostics Inc. (BDI), the U.S. subsidiary of Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, announced today that The U.S. Preven...
Devices, Diagnostics, Oncology
Bracco Diagnostics, Virtual Colonoscopy, colonoscopy, Tagitol, colorectal cancer

Neurotrope Announces Changes to the Board of Directors and Management

Fri, 08/05/2016 - 15:17
NEWARK, N.J., Aug. 5, 2016 -- (Healthcare Sales & Marketing Network) -- Neurotrope, Inc. (NTRP) (the "Company"), focused on developing drugs to treat neurological diseases including Alzheimer's disease, today announced it has reached a settlemen...
Biopharmaceuticals, Neurology, Personnel
Neurotrope, synaptogenesis, Alzheimer's disease

Teva Announces Launch of Generic Gleevec(R) Tablets in the United States

Fri, 08/05/2016 - 15:13
JERUSALEM--(Healthcare Sales & Marketing Network)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced the launch of the generic equivalent to Gleevec®1(imatinib mesylate) tablets,100 mg and 400 mg, in the United States for multip...
Biopharmaceuticals, Generics, Oncology, Product Launch
Teva Pharmaceutical, Gleevec, imatinib

Atossa Genetics Settles Litigation With Besins Healthcare

Fri, 08/05/2016 - 13:43
SEATTLE, WA--(Healthcare Sales & Marketing Network) - Atossa Genetics, Inc. ( NASDAQ : ATOS ) and Besins Healthcare Luxembourg SARL ("Besins") have agreed, pursuant to a Termination Agreement dated August 4, 2016, to terminate their Intellectual ...
Biopharmaceuticals, Oncology, Litigation
Atossa Genetics, Besins Healthcare, Afimoxifene

Allergan and Richter Provide Update on Cariprazine Program

Fri, 08/05/2016 - 13:32
DUBLIN, Ireland and BUDAPEST, Hungary, Aug. 5, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company, and Gedeon Richter Plc., today provided a clinical and regulatory update on cariprazine. For more...
Allergan, Gedeon Richter, cariprazine, VRAYLAR

ScinoPharm and CVie Therapeutics Limited to Jointly Develop New Heart Failure Drug

Fri, 08/05/2016 - 13:24
TAINAN, Taiwan, Aug. 5, 2016 -- (Healthcare Sales & Marketing Network) -- ScinoPharm Taiwan, Ltd (1789.TW) and CVie Therapeutics Limited (CVie) jointly announced the initiation of a discovery and development collaboration to identify the new generation co...
Biopharmaceuticals, Cardiology
ScinoPharm Taiwan, CVie Therapeutics, Istaroxime, heart failure

Ambrx Closes $45M Round of Financing

Thu, 08/04/2016 - 15:52
SAN DIEGO, Aug. 4, 2016 -- (Healthcare Sales & Marketing Network) -- Ambrx, Inc., a clinical stage biotechnology company that discovers and develops first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates, today announced t...
Biopharmaceuticals, Venture Capital
Ambrx, Protein Medicinal Chemistry

DNAtrix Awarded FDA Orphan Products Development Grant for DNX-2401

Thu, 08/04/2016 - 15:48
HOUSTON, Aug. 4, 2016 -- (Healthcare Sales & Marketing Network) -- DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced the award of a $2 million research grant from the FDA's Office of Orphan Produ...
Biopharmaceuticals, Oncology, FDA
DNAtrix, DNX-2401, glioblastoma

Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs

Thu, 08/04/2016 - 15:45
PLYMOUTH MEETING, Pa., Aug. 04, 2016 -- (Healthcare Sales & Marketing Network) -- Inovio Pharmaceuticals, Inc. (INO) today announced the appointment of Dr. Ami Shah Brown as Vice President Regulatory Affairs. Dr. Brown, who joined Inovio in 2011 as Senior ...
Biopharmaceuticals, Personnel
Inovio Pharmaceuticals

Inspyr Therapeutics Appoints Christopher Lowe Chief Executive Officer and Director

Thu, 08/04/2016 - 13:44
SAN ANTONIO--(Healthcare Sales & Marketing Network)--Inspyr Therapeutics, Inc. (OTCQB: NSPX), a clinical-stage biotechnology company developing novel prodrug therapeutics for the treatment of cancer, announces that Christopher Lowe has been appointed Presi...
Biopharmaceuticals, Oncology, Personnel
Inspyr Therapeutics, GenSpera, thapsigargin, Mipsagargin

NuVasive Secures CMS Add-On Payment for Innovative MAGEC System

Thu, 08/04/2016 - 13:37
SAN DIEGO, CA --(Healthcare Sales & Marketing Network) - NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that the U.S. Centers for M...
Devices, Orthopaedic, Neurosurgery, Reimbursement
NuVasive, MAGEC System, growth modulation, spine surgery

New Data Show InCise(TM) Multileaf Collimator for the CyberKnife(R) M6(TM) System may Expand Patient Population Eligible for Precise Radiation Treatments

Thu, 08/04/2016 - 13:27
SUNNYVALE, Calif., Aug. 4, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that more than 45 studies on the use of the CyberKnife® System were presented during poster and oral sessions at the 58th Annual M...
Devices, Oncology
Accuray, CyberKnife, SBRT, radiosurgery, radiotherapy

New Data Demonstrating TomoTherapy(R) System Adaptive Capabilities and Workhorse Reliability Presented at Leading Scientific Meeting for Medical Physicists

Thu, 08/04/2016 - 13:16
SUNNYVALE, Calif., Aug. 4, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that new studies demonstrating the TomoTherapy® System's leading-edge adaptive therapy capabilities and value as a mainstream radi...
Devices, Oncology
Accuray, TomoTherapy, TomoHelical, radiosurgery, radiotherapy

Michael Mosunic Joins Universal Diagnostic Laboratories as President and Chief Operating Officer

Wed, 08/03/2016 - 16:46
VAN NUYS, Calif., Aug. 3, 2016 -- (Healthcare Sales & Marketing Network) -- Universal Diagnostic Laboratories, a leader in women's and men's health diagnostics, today announced the appointment of Michael Mosunic as the company's President and Chief Operat...
Diagnostics, Personnel
Universal Diagnostic Laboratories

FDA Approves FLONASE(R) Sensimist(TM) Allergy Relief

Wed, 08/03/2016 - 16:42
WARREN, N.J., Aug. 3, 2016 -- (Healthcare Sales & Marketing Network) -- GSK Consumer Healthcare announced today that the U.S. Food and Drug Administration (FDA) has approved FLONASE® Sensimist™ Allergy Relief (fluticasone furoate, 27.5 mcg spray) as a...
Biopharmaceuticals, FDA
GlaxoSmithKline, FLONASE, Sensimist, fluticasone

Ornim Raises $20 Million in Latest Equity Financing Round

Wed, 08/03/2016 - 16:37
KFAR SABA, Israel, August 3, 2016 -- (Healthcare Sales & Marketing Network) -- Ornim Inc. ("Ornim" or "the Company"), an emerging, commercial-stage medical technology company specializing in clinical research, development, and distribu...
Devices, Monitoring, Venture Capital
Ornim, c-FLOW, UTLight, cerebral blood flow

Novartis CDK4/6 Inhibitor LEE011 (Ribociclib) Receives FDA Breakthrough Therapy Designation as First-Line Treatment for HR+/HER2- Advanced Breast Cancer

Wed, 08/03/2016 - 16:33
EAST HANOVER, N.J., Aug. 3, 2016 -- (Healthcare Sales & Marketing Network) -- Novartis announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to LEE011 (ribociclib), in combination with letrozole, for t...
Biopharmaceuticals, Oncology, FDA
Novartis, ribociclib, breast cancer

Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical

Wed, 08/03/2016 - 15:29
DUBLIN, Aug. 2, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a global pharmaceutical company, today announced that it has entered into a definitive agreement under which Teva Pharmaceutical Industries Ltd. will acquire Allergan's ...
Biopharmaceuticals, Distribution, Acquisitions
Allergan, Teva Pharmaceutical

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong